Immuneering (IMRX) Total Non-Current Liabilities (2022)
Immuneering has reported Total Non-Current Liabilities over the past 1 years, most recently at $8.4 million for Q2 2022.
Immuneering has reported Total Non-Current Liabilities over the past 1 years, most recently at $8.4 million for Q2 2022.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month